Lonza is a pioneer and world leader in the CDMO industry, setting the pace with cutting-edge science, smart technology, and lean manufacturing. United by a common purpose, we turn our customers’ breakthrough innovations into viable therapies and manufacture the medicines of tomorrow. Founded in Switzerland in 1897, our company is the first and original CDMO, and today we are more dynamic, agile and forward-focused than ever before. As one of the largest Western CDMOs, we bring together a global team of around 18,500 colleagues across five continents to deliver comprehensive, integrated solutions for our customers' complex needs. For our customers and their patients, we bring quality, safety and reliability to bring life-enhancing and life-saving treatments to market at speed and at scale. For our colleagues, we strive to create a sense of belonging and inclusion where every person can thrive and bring their best.
解锁市场时间线与信号动态
最近 90 天内有 1,059 个信号。
该公司进入各个市场的顺序 — 从最早到最新
Quality Engineering, QA Expert, Commissioning & Qualification Audit and Inspection Support
注册以查看完整信号动态
Lonza 的国际扩张与竞争对手的对比情况
Lonza你条形图显示所对比公司之间的相对规模。
5 项指标| 公司 | 市场 | 新市场 | 势头 | 活动 | 扩张评分 |
|---|---|---|---|---|---|
 Lonza你 | 25 | 0 | -18% | 988 | 33 |
快速扩张——最近 90 天新增 911 个职位，较上一周期增长 172%。 以 Engineering 为主，集中在 瑞士。
Hyderabad, Telangana, India · 今天
Quality Engineering, QA Expert, Commissioning & Qualification Audit and Inspection Support
Slough, England, United Kingdom · 前天
Associate Principal QA Specialist
Gurugram, Haryana, India · 昨天
IT Commercial Head
在技术栈中检测到 36 项技术。
覆盖 188 个市场 的 14 个进行中的广告系列。
已结束最近 90 天获 18 次提及。
和铂医药公布2026年上半年收入8.34亿人民币(同比增长20.9%),净利润4.42亿人民币,连续七个半年度盈利,多项临床里程碑及战略合作取得进展。
基于AI的抗体药物开发平台Mirabo Biotechnology在Stonebridge Ventures领投、FuturePlay参与下,完成40亿韩元(约300万美元)Pre-A轮融资,使用其MiRAiQ AI引擎。
Artisan Partners在第四季度建仓GE Aerospace、康宁、意法半导体和Robinhood,同时增持DoorDash和基恩士。该公司退出Cencora、龙沙集团和Medline,并减持AMD、Lam、Amer Sports和腾讯。
解锁已验证邮箱与直拨电话
免费 · 无需信用卡
关于 Lonza 的业务、市场和增长信号的快速解答。
